BioCatalyst

HUMA — Humacyte, Inc. catalysts

1 verified catalyst event(s) for Humacyte, Inc. (ticker HUMA). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-10-01 — To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10 (month)
in 3mo
ESTIMATED
 READOUT
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With
Phase 3 · End Stage Renal Disease (ESRD)
 HUMA Humacyte, Inc. Acellular Tissue Engineered Vessel (ATEV ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.